News | November 05, 2006

Siemens Calls for New Therapeutic Approach

Holger Schmidt, the new president of Siemens Medical Solutions Oncology Care Division, requested today at ASTRO that the scientific and clinical oncology communities “break down the barriers of conventional thinking and explore the furthest reaches of the creative and innovative spirit”, as Siemens advocates changing the approach to treating cancer.
“By transforming the therapeutic approach, we can connect those pieces and complete the picture of truly personalized cancer care," said Schmidt.
Schmidt and John Buatti, M.D., the University of Iowa, pointed to developments in adaptive radiation therapy, including systems for volume-guided radiation therapy (VGRT) and dose-guided radiation therapy (DGRT). They also emphasized the progress in genomic and proteomic tools as examples of advances in oncology care that are redefining the therapeutic approach and creating a cohesive healthcare continuum in oncology.
“The more information you have, the better the care can be - it's as simple as that,” said Dr. Buatti. “With more information, we can be more precise in our decisions and more precise in the care we provide; however, more can be done to transform the therapeutic approach and improve the quality of care.”

Related Content

statins, heart scan, CT scan
News | March 25, 2014
As long as inexpensive statins, which lower cholesterol, are readily available and patients do not mind taking them, it...
News | September 30, 2013
A study by Cutting Edge Information found that pharmaceutical companies measure cost per patient per month to allow...
Feature | February 21, 2013
  Time Magazine releases the dramatic findings of a months-long investigation by contributor Steven Brill into how...
Feature | April 02, 2012
It seems a picture is worth more than a thousand words for people who see evidence of coronary artery disease, the most...
News | November 18, 2011
November 17, 2011 — Westside Medical Imaging of Beverly Hills announces the availability of high resolution magnetic...
News | October 21, 2009
October 21, 2009 – King Pharmaceuticals Inc. said today the U.S. Food and Drug Administration issued a complete...
News | October 05, 2009
October 5, 2009 – A new analysis reaffirms that Lexiscan (regadenoson) Injection, the first selective A2A adenosine...
News | July 10, 2009
July 10, 2009 – New British Heart Foundation (BHF) research(1) revealed today suggests for the first time that the way...
News | April 06, 2009
April 7, 2009 - Lantheus Medical Imaging Inc. has acquired the U.S., Canadian and Australian rights to MS-325 (...
News | June 16, 2008
June 17, 2008 - One of the biggest challenges in fighting tuberculosis is simply getting patients to take their medic
Overlay Init